SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-19-000114
Filing Date
2019-11-14
Accepted
2019-11-14 16:27:35
Documents
5
Period of Report
2019-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant-8xkatmnov2019.htm 8-K 36672
2 EXHIBIT 1.1 jefferies_opiant-salesagen.htm EX-1.1 255818
3 EXHIBIT 5.1 opiant-51legalopinionoct20.htm EX-5.1 11090
4 opiant51legalopiniono_image1.gif GRAPHIC 5839
5 opiant51legalopiniono_image2.gif GRAPHIC 10165
  Complete submission text file 0001385508-19-000114.txt   327291
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 191220795
SIC: 1000 Metal Mining